Find the key signatures of cancer through single-cell multi-omics.
You seek more than patterns. You seek the sources of disease. The Tapestri Platform analyzes genotype and phenotype simultaneously from single cells, revealing the heterogeneity of your samples with unprecedented resolution. Leverage single-cell multi-omics to target comprehensive biomarkers that help stratify patients more precisely, signal resistance as it begins, and predict relapse.
Cancer is a complex disease with a mix of cells in varied states. Understanding the effect of genotype on immunophenotype at the single-cell level reveals disease processes and ultimately enables better therapies. A single-cell multi-omics approach is the only way to achieve full resolution of tumor heterogeneity. Perform true multi-omics with simultaneous detection of SNVs, CNVs, and cell-surface proteins at the single-cell level.
Correlate immunophenotype with genotype from the same cell.
Distinguish subclones from minimal residual disease with single-cell multi-omics based on SNVs, CNVs, and protein expression.
Eliminate inferences while saving on research budgets and analysis times.
Explore insights of single-cell multi-omics in myeloid malignancies
Ross Levine, MD, Memorial Sloan Kettering Cancer Center
Integrate seamlessly into your existing NGS workflow with sample prep and analysis solutions using the Tapestri single-cell sequencing platform
With our single-cell sequencing platform, use the Tapestri Instrument, reagents, and consumables up-front of your NGS system and then Tapestri Pipeline and Tapestri Insights software for data analysis and visualization.